Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at 2022 Chem Outsourcing Conference

Page View:


We are very pleased to announce that Medicilon will participate in the 2022 Chem Outsourcing Conference for Pharmaceutical Professionals. It kicks off on September 8, 2022 in Parsippany, the Medicilon American team will be present throughout the event. We sincerely invite you to come to have a discussion with us!

Organizer: ChemOutsourcing

Date: September 8-9, 2022

Location: Parsippany, NJ Hilton


About 2022 Chem Outsourcing Conference

ChemOutsourcing is the largest USA-based API and Pharmaceutical Ingredients Sept show, Mark Alexay is the President, CEO & Founder of ChemOutsourcing, he launched the show in Sept 2007, attracting annually 700-800 customers, project and executive management and business development personnel from the pharmaceutical, biotech, chemical, and chemistry services industries from 30 countries. The show spans every point on chemical supply chain, the API development supply chain spanning raw materials, RSM, catalysts, drug discovery, analytical, QA/QC, drug product and so on.


About Medicilon

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. We provide one-stop customized R&D solutions ranging from precise drug targeting to IND filing assistance. Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.


Medicilon Medicinal Chemistry Services

At Medicilon, Our medicinal chemistry team is capable of flexibly applying computer chemistry to assist compound design process. In the meantime, we apply advanced drug discovery technologies, including proteolysis-targeting chimera (PROTAC), DNA-encoded chemical library (DEL) and antibody drug conjugation (ADC). We are also proud of our rich experience in innovative design and patent strategies that complement our technologies. In addition, our responsive project management and effective communication help optimize our project delivery.


Medicilon Synthetic Chemistry Services

Medicilon is proud of our extensive expertise in synthetic organic chemistry. With a team of over 1200 chemists, our synthetic chemistry department is capable of the independent design of synthesis pathways and complex compound treatments, key to helping accelerate our clients' drug discovery. As we pay great attention to scientific morality, we protect our clients' intellectual property rights tirelessly and guarantee data integrity. Furthermore, our projects are always undertaken with a fundamental focus on safety and green chemistry.



 AI supported route design and process optimization;

 Custom chemical synthesis;

 Synthesis of standards, reference compounds, and molecular probes;

 Synthesis of high-quality compounds from milligram to kilogram;

 Synthesis and resolution of chiral compounds and so on.

Relevant newsRelevant news